Bone

St. Baldrick's Foundation and Funding Partners Create New Super Grant to Further Progress in Osteosarcoma Research

Retrieved on: 
Tuesday, June 6, 2023
Neoplasm, Huang, Bangladesh Technical Education Board, Cloud, Patient, Disease, MYC, University, Genetics, Friends, Children's Cancer Research Fund, Osteosarcoma, Hope, Organization, Child, Diagnosis, Hospital, Death, Metastasis, FOT, Parent, CureSearch for Children's Cancer, Cancer, Philadelphia, Translation, Grief, Family, Einstein Medical Center Philadelphia, Perseverance, Drug development, Education, Rage, Clinical trial, National Institutes of Health Clinical Research Training Program, Drug combination, Bone, OSC, Pharmaceutical industry, Vaccine, Nursing, St. Baldrick's Foundation, Research

LOS ANGELES, June 6, 2023 /PRNewswire/ -- For more than 40 years the main treatment for pediatric osteosarcoma has not changed. Patients with this type of aggressive bone cancer, most often diagnosed in teens, are in desperate need of new options. Fewer than 30% of patients survive when osteosarcoma has spread beyond the primary tumor at diagnosis. 

Key Points: 
  • To make a significant impact for kids fighting osteosarcoma, five funding partners have banded together with St. Baldrick's to support a new grant - The Fight Osteosarcoma Together (FOT) Super Grant.
  • As you know, we are still using the same, decades-old chemotherapy regimen to treat patients with osteosarcoma."
  • New partners joining to fund this grant are CureSearch for Children's Cancer and the Zach Sobiech Osteosarcoma Fund of Children's Cancer Research Fund.
  • The Zach Sobiech Osteosarcoma Fund , which supports groundbreaking osteosarcoma research nationwide through Children's Cancer Research Fund , is also a funding partner.

High Schooler empowers Youth with Nonprofit "Unlimited Potential", raises $100,000 for Sports Medicine Research and Advocacy

Retrieved on: 
Saturday, June 3, 2023
Eastside Preparatory School, Bionics, Volunteering, Osteochondrodysplasia, Special Olympics, Sports medicine, Bone, University, Olympic Games, Goodreads, Seattle Children's, Nicholas Institute of Sports Medicine and Athletic Trauma, Angular limb deformity, UP, Research, Multimedia, DSM-IV codes, Science, Athlete, Organization, Hospital, University of Washington School of Medicine, Sport, Disability studies, STEM, Fred Hutchinson Cancer Research Center, Barnes & Noble, Environment, Mental health, Muscular dystrophy, Wheeling University, Unlimited, Dentistry, Book, Online shopping, Amazon

Rakshith Srinivasan, a driven high school student from Eastside Preparatory School, Kirkland, WA, has founded a nonprofit organization called Unlimited Potential (UP).

Key Points: 
  • Rakshith Srinivasan, a driven high school student from Eastside Preparatory School, Kirkland, WA, has founded a nonprofit organization called Unlimited Potential (UP).
  • UP is dedicated to generating awareness and fundraising for sports medicine research, aiming to empower children with physical disabilities and chronic health conditions to participate in school sports with ease.
  • Rakshith Srinivasan's passion for sports medicine research and STEM awareness has led him to create UP and make a difference in the lives of young athletes within the community.
  • Unlimited Potential focuses on collaborating with sports medicine researchers, sports medicine research labs, orthopedic doctors and universities to raise awareness about groundbreaking research and to secure funds for hospitals and labs across North America.

Ready, Set, Register: Sign up now for St. Jude Memphis Marathon Weekend

Retrieved on: 
Thursday, June 1, 2023
Fund Raising, Foundation, Philanthropy, Hospitals, Science, Family, Sports, Consumer, Entertainment, Running, Health, Events, Concerts, Other Philanthropy, Research, Other Health, Children, Oncology, Survival rate, Volunteering, Travel, Housing, Food, Bone, Friends, NCI-designated Cancer Center, ALSAC, Cancer, National Cancer Institute (Egypt), Hope, Multimedia, Juice, National Cancer Institute, Patient, Child, Love, Hospital, Juice Plus, Nursing, Jude the Apostle

Now is the time to register for St. Jude Memphis Marathon® Weekend presented by Juice Plus+, happening Saturday, Dec. 2.

Key Points: 
  • Now is the time to register for St. Jude Memphis Marathon® Weekend presented by Juice Plus+, happening Saturday, Dec. 2.
  • View the full release here: https://www.businesswire.com/news/home/20230601005442/en/
    Now is the time to register for St. Jude Memphis Marathon® Weekend presented by Juice Plus+, happening Saturday, Dec. 2.
  • Saving children.®
    Recently crowned the top marathon in Tennessee and one of the 2023 “Runners Choice: Best Marathons in the U.S.” according to a recent RaceRaves poll, St. Jude Memphis Marathon Weekend is the largest single-day fundraiser for St. Jude.
  • Support the St. Jude mission by donating at stjude.org , liking St. Jude on Facebook , following St. Jude on Twitter , Instagram , LinkedIn and TikTok , and subscribing to its YouTube channel.

Global Rigid Endoscopes Market to 2030: Preference for Minimally Invasive Surgical Techniques over Standard Surgeries Drives Growth - ResearchAndMarkets.com

Retrieved on: 
Tuesday, May 30, 2023
Science, Health, Research, Medical Devices, COVID-19, Endometriosis, Conditional sentence, Karl Storz SE, Cancer, Ageing, WHO, Bone, Prevalence, Endoscopy, Gynaecology, Patient satisfaction, Kidney, Laparoscopy, Dentistry, Medical device, Hospital

The high burden of cancer, gynecological disorders, urothelial disorders, and others are contributing to the demand for surgeries, further supporting the demand for rigid endoscopes in the market.

Key Points: 
  • The high burden of cancer, gynecological disorders, urothelial disorders, and others are contributing to the demand for surgeries, further supporting the demand for rigid endoscopes in the market.
  • The COVID-19 pandemic had a negative impact on the market owing to the cancellation and decline in elective procedures during the pandemic.
  • The preference for minimally invasive surgical techniques over standard surgeries, greater patient satisfaction, enhanced economic viability, and shorter hospital stays are expected to support the demand for endoscopic surgeries and thus support the market of rigid endoscopes.
  • This high share is attributable to the significant number of endoscopic surgeries conducted in outpatient facilities, which is supporting the segment market growth.

Resolutions of Bioretec Ltd´s Annual General Meeting and the constitutive meeting of the Board of Directors

Retrieved on: 
Friday, May 26, 2023
Travel, Bank statement, Health care, Option, Annual, Ernst & Young, Annual general meeting, Coronavirus Scientific Advisory Board, Bone, Small Business Health Options Program, Committee, Tax, Audit committee, Chairperson, African Tax Administration Forum, EUR, Patient, Trauma, Remuneration, Nomination, Cryptocurrency, Holding company, Health insurance, Accounting, Security (finance), Management

Number of members of the Board of Directors, election of members of the Board, and their remuneration

Key Points: 
  • Number of members of the Board of Directors, election of members of the Board, and their remuneration
    The Annual General Meeting resolved that the number of members of the Board of Directors shall be six (6).
  • The term of the Board of Directors will end at the closing of the Annual General Meeting 2024.
  • The Annual General Meeting elected auditing firm Ernst & Young Oy as the auditor of the company until the closing of the 2024 Annual General Meeting.
  • At its constitutive meeting held after the Annual General Meeting, the Board of Directors of Bioretec Ltd elected Tomi Numminen as the Chairperson of the Board.

Resolutions of Bioretec Ltd´s Annual General Meeting and the constitutive meeting of the Board of Directors

Retrieved on: 
Friday, May 26, 2023
Travel, Bank statement, Health care, Option, Annual, Ernst & Young, Annual general meeting, Coronavirus Scientific Advisory Board, Bone, Small Business Health Options Program, Committee, Tax, Audit committee, Chairperson, African Tax Administration Forum, EUR, Patient, Trauma, Remuneration, Nomination, Cryptocurrency, Holding company, Health insurance, Accounting, Security (finance), Management

Number of members of the Board of Directors, election of members of the Board, and their remuneration

Key Points: 
  • Number of members of the Board of Directors, election of members of the Board, and their remuneration
    The Annual General Meeting resolved that the number of members of the Board of Directors shall be six (6).
  • The term of the Board of Directors will end at the closing of the Annual General Meeting 2024.
  • The Annual General Meeting elected auditing firm Ernst & Young Oy as the auditor of the company until the closing of the 2024 Annual General Meeting.
  • At its constitutive meeting held after the Annual General Meeting, the Board of Directors of Bioretec Ltd elected Tomi Numminen as the Chairperson of the Board.

QSAM Biosciences Expands its Study of CycloSam® in the Treatment of Bone Cancer; Opens Patient Enrollment at Key Chicago Center, Insight Hospital and Medical Center

Retrieved on: 
Tuesday, May 23, 2023
Partnership, Bone, Cancer, Osteosarcoma, OTCQB, Breast, Prostate, MD, Patient, Sarcoma, Medical Center, RLS, Nuclear pharmacy, QSAM, Medical imaging, Pharmaceutical industry

QSAM’s study is a multiple center, open label, dose escalation clinical trial intended to determine the maximum tolerated dose of CycloSam® in patients, as well as assess early efficacy signals. Patients with bone cancer that has metastasized from the breast, lungs, prostate or other organs, as well as patients with cancer that has originated in the bone such as osteosarcoma and Ewing’s Sarcoma – diseases that mostly affect children and young adults -- may be eligible.

Key Points: 
  • QSAM’s study is a multiple center, open label, dose escalation clinical trial intended to determine the maximum tolerated dose of CycloSam® in patients, as well as assess early efficacy signals.
  • Patients with bone cancer that has metastasized from the breast, lungs, prostate or other organs, as well as patients with cancer that has originated in the bone such as osteosarcoma and Ewing’s Sarcoma – diseases that mostly affect children and young adults -- may be eligible.
  • "We are pleased to be working with the excellent team at Insight Hospital and Medical Center to continue the expansion of our drug development program for CycloSam® in the large population center of Chicago,” stated Douglas R. Baum, CEO and co-founder of QSAM.
  • “Therapeutic radiopharmaceuticals like CycloSam® represent a novel and potentially important treatment option for patients suffering from this debilitating and deadly disease.”

Thirteen States Take Action to Combat Osteoporosis and Strengthen Bone Health

Retrieved on: 
Tuesday, May 23, 2023
Osteoporosis, Bone, Medicare, Incidence, Fracture, BHOF, Bone health, Clinical, Legislation, Dietary supplement

ARLINGTON, Va., May 23, 2023 /PRNewswire/ -- Thirteen states across the nation have taken steps through legislation and executive action to tackle the costly and growing problem of osteoporosis. Arizona, Connecticut, Illinois, Kentucky, Maine, Michigan, New Hampshire, New York, Oklahoma, Pennsylvania, Virginia, West Virginia, and Wisconsin have passed, introduced legislation, or made gubernatorial proclamations calling for steps to raise awareness, take action and declare May 2023 as Osteoporosis Awareness and Prevention Month. The states responded to a nationwide effort launched by the Bone Health and Osteoporosis Foundation (BHOF) to inspire states to get the word out about this debilitating disease and its extremely high associated costs. The 2021 Milliman Research Report: Medicare Cost of Osteoporotic Fractures: The Clinical and Cost Burden of Fractures Associated with Osteoporosis utilized the latest, most detailed state-level review of the incidence of osteoporotic fractures, their health care impact, and Medicare costs. The report was commissioned by BHOF.

Key Points: 
  • The states responded to a nationwide effort launched by the Bone Health and Osteoporosis Foundation (BHOF) to inspire states to get the word out about this debilitating disease and its extremely high associated costs.
  • "More than 54 million Americans are affected by osteoporosis or low bone mass, putting them at high risk of bone fractures.
  • We commend these great state leaders for their efforts to raise awareness about bone health and osteoporosis."
  • There are simple steps that people and their elected officials can take to strengthen bone health and reduce the burden of osteoporosis.

LG CHANNELS FEATURES NCAA SPRING CHAMPIONSHIPS AND POPULAR MOVIE TITLES FOR MAY

Retrieved on: 
Wednesday, May 17, 2023
NCAA, CSI, WebOS, The Devil's Own, Money Train, SWAT, DII, The House Bunny, James Street, Bone, Electronics, Channel, EST, Team tennis, LG Electronics, Tourist, The Red Green Show, Western United States, Police, S.W.A.T, Burns, Red green, FBI, Sport, LG, Devil, DIII, Tourism, Forensic Files, News, House, Ion Mystery, Television, Communications satellite, Private investigator, Zohan, Western (genre)

This month LG Smart TV owners can also watch the NCAA® DII and DIII Spring Championship games streaming on the NCAA Championships Channel (100) and via the NCAA tab on the LG Channels Home App.

Key Points: 
  • This month LG Smart TV owners can also watch the NCAA® DII and DIII Spring Championship games streaming on the NCAA Championships Channel (100) and via the NCAA tab on the LG Channels Home App.
  • LG Channels offers a wide selection of premium live and on-demand programming, including movies, TV shows, news, sports, children's programs and more.
  • LG smart TV owners can easily discover their favorite programs by launching the LG Channels application on their LG TV's webOS platform.
  • Visit the LG Channels Home App for more free on-demand titles available this month including, "Money Train," "The Tourist," "2012," "The Devil's Own," "The House Bunny" and more.

QSAM Biosciences and RLS Announce Clinical and Commercial Supply Agreement for Promising Clinical-Stage Metastatic and Primary Bone Cancer Treatment, CycloSam®

Retrieved on: 
Tuesday, May 16, 2023
Tissue, Bone Cancer Research Trust, Radiation, Bone, Half-life, OTCQB, Toxicity, Pharmacy, CDMO, Clinical trial, Patient, RLS, QSAM, FDA, Medical imaging, Pharmaceutical industry

Austin, TX and Lake Zurich, IL, May 16, 2023 (GLOBE NEWSWIRE) -- QSAM Biosciences, Inc. (OTCQB: QSAM), a clinical stage biotechnology company developing next-generation therapeutic radiopharmaceuticals, and RLS (USA) Inc., the third-largest nuclear medicine pharmacy network in the U.S., announced today a commercial supply and clinical dose preparation agreement for the therapeutic radiopharmaceutical drug candidate CycloSam® (Samarium-153 DOTMP), a promising clinical-stage treatment for metastatic and primary bone cancer in adults and children.

Key Points: 
  • (OTCQB: QSAM), a clinical stage biotechnology company developing next-generation therapeutic radiopharmaceuticals, and RLS (USA) Inc. , the third-largest nuclear medicine pharmacy network in the U.S., announced today a commercial supply and clinical dose preparation agreement for the therapeutic radiopharmaceutical drug candidate CycloSam® (Samarium-153 DOTMP), a promising clinical-stage treatment for metastatic and primary bone cancer in adults and children.
  • QSAM is actively enrolling patients with metastatic bone cancer in a Phase I clinical trial for CycloSam® across three clinical sites in the United States with additional sites planned.
  • The RLS agreement is expected to support QSAM’s clinical research and potential future commercial use of CycloSam®.
  • Stephen Belcher, CEO of RLS, added, “RLS is proud to partner with the talented management team at QSAM in support of these important clinical trials.